Bankruptcy judge rejects the healthcare-products company’s third attempt to resolve mass talc lawsuits through chapter 11.

J&Js failure to win approval of an $8 billion bankruptcy plan for its talc liabilities is the latest court ruling to pare back the use of chapter 11 to resolve mass torts and could limit the appeal of bankruptcy for companies looking to drive settlements.

Johnson & Johnson, the pharmaceutical and biotech company, has spent years trying to put its talc legal issues behind it. Its latest attempt just failed again.The stock had fallen 5.3% to $157.04 in early trading Tuesday after a bankruptcy judge in Texas rejected a proposal that would have ended current and future lawsuits related to the talc products’ alleged links to cancer.

A Houston bankruptcy judge has rejected Johnson & Johnson’s to use federal bankruptcy procedures to force a settlement with 90,000 women — including 2,558

Now that the JNJ stock has seen a 7% fall, does the current price point make it attractive? Going by what you pay per dollar of sales or profit, JNJ stock looks moderate compared to the broader market.

Judge Christopher Lopez ruled that the company's attempt to use bankruptcy, filed under different names like Red River, was nothing more than a delay tactic. This decision clears the way for victims,

A U.S. bankruptcy court judge has denied Johnson & Johnson’s settlement plan related to baby powder containing talc, providing another setback in the company’s efforts to resolve the matter

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.